Thursday, May 04, 2017 5:10:12 PM
https://www.sec.gov/Archives/edgar/data/1123312/000119983515000565/yasheng_defm14c-16686.htm
They can't book the value of the swapped in management rights. They have to book them AT COST. The result is that gross margin could be as high as 70% (Almost no depreciation).
The management rights were acquired a long time ago (before the swap). They have less value today as a result of depreciation.
Ms. Wu was mistakenly removed from the BOD in the 10-K. That was all the 10-K/A amendment was about.
As to what the company is up to, I think a little imagination can go a long way in solving that mystery. Currently, HERB can't transfer a single penny to parent without giving the minority shareholders their fair share. And they used to do it all the time (every penny) before the asset swap. So they have to get rid of us. Going dark is not an option IMO, as the cash position will go up by roughly $150M every year. All free cash flow.
Recent HERB News
- Form C-AR - Annual Report • Edgar (US Regulatory) • 02/26/2024 01:00:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 08:51:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 07:00:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM